NOD2 and inflammatory bowel disease: Overall, we identified 64 homozygous or putative compound heterozygous NOD2 variant carriers in the DiscovEHR IBD cohort, accounting for 6.5% of patients with an IBD diagnosis in this clinical population (Fig. 1, Supplementary Table 4).